Hims&Hers Health declines as Lilly launches single-dose vials of Zepbound
Go back to Hims&Hers Health declines as Lilly launches single-dose vials of Zepbound| (NYSE: HIMS) | Delayed: 29.28 +0.89 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.39 | 52 Week High | $ | |||
| Open | $28.00 | 52 Week Low | $ | |||
| Day High | $29.65 | P/E | N/A | |||
| Day Low | $27.31 | EPS | $ | |||
| Volume | 16,700,736 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1181.89 +30.90 (2.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1150.99 | 52 Week High | $88.16 | |||
| Open | $1156.67 | 52 Week Low | $67.88 | |||
| Day High | $1197.79 | P/E | 273.59 | |||
| Day Low | $1151.00 | EPS | $4.32 | |||
| Volume | 2,418,288 | |||||
